Published in Boll Ist Sieroter Milan on January 01, 1981
Hepatitis B in general practice: epidemiology, clinical and serological features, and control. Br Med J (Clin Res Ed) (1987) 1.23
Hepatitis C virus infection in spouses: sexual transmission or common exposure to the same risk factors? Am J Gastroenterol (2001) 2.82
Risk factors in community-acquired chronic hepatitis C virus infection: a case-control study in Italy. J Hepatol (1996) 2.19
Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitis. Lancet (1992) 2.13
Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR. Genes Immun (2003) 1.88
Biochemical characterization and protein kinase C dependency of monokine-inducing activities of Toxoplasma gondii. Infect Immun (1996) 1.79
Hepatitis C virus infection in pregnancy. Br J Obstet Gynaecol (1996) 1.70
Validity and reliability of the Italian version of the Chronic Liver Disease Questionnaire (CLDQ-I) for the assessment of health-related quality of life. Dig Liver Dis (2005) 1.69
Histological features after liver transplantation in alcoholic cirrhotics. J Hepatol (2001) 1.69
How should patients with hepatocellular carcinoma be staged? Validation of a new prognostic system. Cancer (2000) 1.68
Chronic atrophic gastritis and Helicobacter pylori infection in primary biliary cirrhosis: a cross-sectional study with matching. Ital J Gastroenterol Hepatol (1997) 1.63
Oxidative DNA damage accumulation in gastric carcinogenesis. Gut (1998) 1.57
Mitochondrial and other tissue antibodies in relatives of patients with primary biliary cirrhosis. Clin Exp Immunol (1972) 1.50
Long-term oral plus topical mesalazine in frequently relapsing ulcerative colitis. Dig Liver Dis (2005) 1.49
Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis. J Hepatol (1995) 1.48
Prevalence of antibodies against hepatitis C virus in the elderly: a seroepidemiological study in a nursing home and in an open population. The Collaborative Group. Gerontology (2000) 1.44
Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis. Cancer (1999) 1.43
Treatment of primary sclerosing cholangitis with low-dose ursodeoxycholic acid: results of a retrospective Italian multicentre survey. Dig Liver Dis (2003) 1.42
Upper gastrointestinal injury caused by diquat. Gastrointest Endosc (1992) 1.41
Carbohydrate-induced thermogenesis in liver cirrhosis: glucose vs. fructose. Nutrition (1995) 1.39
Serum CA 19-9 and alpha-fetoprotein levels in primary hepatocellular carcinoma and liver cirrhosis. Cancer (1991) 1.39
Fasting hyperglycaemia following trans-catheter arterial chemo-embolization for hepatocellular carcinoma in cirrhosis. Ital J Gastroenterol Hepatol (1997) 1.39
Hormonal treatment of hepatocellular carcinoma. J Hepatol (1991) 1.38
Chronic hepatitis D: a vanishing Disease? An Italian multicenter study. Hepatology (2000) 1.34
Hepatitis B virus infection in prisons. A seroepidemiological survey in prisoners and attending staff. J Hyg (Lond) (1982) 1.32
Disease fingerprinting with cDNA microarrays reveals distinct gene expression profiles in lethal type 1 and type 2 cytokine-mediated inflammatory reactions. FASEB J (2001) 1.30
Immunological and histological studies in primary biliary cirrhosis. J Clin Pathol (1970) 1.29
Type 1 diabetes mellitus in patients with chronic hepatitis C before and after interferon therapy. Aliment Pharmacol Ther (2003) 1.23
Epidemiology of HCV infection. Curr Pharm Des (2008) 1.23
Liver transplantation: the Italian experience. Dig Liver Dis (2002) 1.19
Hepatitis C virus infection, HBsAg carrier state and hepatocellular carcinoma: relative risk and population attributable risk from a case-control study in Italy. J Hepatol (1992) 1.15
Occurrence of Australia antigen in chronic hepatitis in Italy. Gastroenterology (1972) 1.09
Otilonium bromide in irritable bowel syndrome: a double-blind, placebo-controlled, 15-week study. Aliment Pharmacol Ther (1998) 1.08
Characteristics of hepatocellular carcinoma in Italy. J Hepatol (1998) 1.08
[Seroepidemiologic research on the antipoliomyelitic immunity in adult unvaccinated subjects]. Boll Ist Sieroter Milan (1975) 1.07
The Italian experience on paediatric liver transplantation: 1988-1999 report. Dig Liver Dis (2002) 1.06
Discrepancies between reported food intolerance and sensitization test findings in irritable bowel syndrome patients. Am J Gastroenterol (1999) 1.05
Pure lipoma of the uterus in association with endometrial carcinoma. Eur J Obstet Gynecol Reprod Biol (1998) 1.04
Fine-needle biopsy in focal liver lesions: the usefulness of a screening programme and the role of cytology and microhistology. Ital J Gastroenterol (1995) 1.04
The role of cysteine and serine proteases in colorectal carcinoma. Cancer (1999) 1.03
Follow-up in gastric dysplasia patients. Am J Surg Pathol (1989) 1.03
Hepatitis C virus: from oxygen free radicals to hepatocellular carcinoma. J Viral Hepat (2007) 1.02
Gastric antioxidant, nitrites, and mucosal lipoperoxidation in chronic gastritis and Helicobacter pylori infection. J Clin Gastroenterol (1996) 1.01
Oxidative DNA damage in circulating leukocytes occurs as an early event in chronic HCV infection. Free Radic Biol Med (1999) 0.99
Bone metabolism in orthotopic liver transplantation: a prospective study. Liver Transpl Surg (1998) 0.99
Unresectable hepatocellular carcinoma in cirrhosis: survival, prognostic factors, and unexpected side effects after transcatheter arterial chemoembolization. Dig Dis Sci (1996) 0.98
Hepatitis A infection: a seroepidemiological study in young adults in North-East Italy. Eur J Epidemiol (1997) 0.97
Prevalence of Toxoplasma gondii antibodies among children and teenagers in Italy. Microbiologica (1991) 0.97
Hepatocyte proliferative activity in chronic liver damage as assessed by the monoclonal antibody MIB1 Ki67 in archival material: the role of etiology, disease activity, iron, and lipid peroxidation. Hepatology (1996) 0.97
What do patients want to know about their inflammatory bowel disease? Ital J Gastroenterol (1993) 0.97
Unresectable hepatocellular carcinoma: a prospective controlled trial with tamoxifen. J Hepatol (1990) 0.96
AIDS information campaign has significantly reduced risk factors for HIV infection in Italian drug abusers. J Acquir Immune Defic Syndr (1988) 0.96
Seroepidemiology of pertussis in Italy. Rev Infect Dis (1992) 0.96
Adrenal androgen-secreting carcinoma in a fertile woman. Acta Eur Fertil (1997) 0.95
Cytokine, infiltrating macrophage and T cell-mediated response to development of primary and secondary human liver cancer. Dig Liver Dis (2002) 0.95
Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy. Br J Obstet Gynaecol (1994) 0.95
Altered esophageal pain threshold in irritable bowel syndrome. Dig Dis Sci (1993) 0.95
Hepatitis B virus infection in Cameroon: a seroepidemiological survey in city school children. J Med Virol (1991) 0.95
Is tissue polypeptide antigen more accurate than serum CEA for diagnosing pancreatic cancer? J Clin Pathol (1986) 0.95
Gastric cell c-AMP stimulating autoantibodies in duodenal ulcer disease. Gut (1988) 0.95
Decrease in HDV endemicity in Italy. J Hepatol (1997) 0.94
Proteases in gastrointestinal neoplastic diseases. Clin Chim Acta (2000) 0.93
The impact of liver disease and medical complications on quality of life and psychological distress before and after liver transplantation. J Hepatol (2000) 0.93
Tissue polypeptide antigen (TPA) in pancreatic cancer diagnosis. Br J Cancer (1985) 0.93
Association between inflammatory bowel disease and sarcoidosis. Report of two cases and review of the literature. Scand J Gastroenterol (1995) 0.93
CA 19-9 in the differential diagnosis between pancreatic cancer and chronic pancreatitis. Eur J Cancer Clin Oncol (1985) 0.93
Baseline seroepidemiology of hepatitis A virus infection among children and teenagers in Italy. Infection (1991) 0.93
[Some aspects of humoral and cellular immunity in acute viral hepatitis. Diagnostic and prognostic prospects]. Rev Med Chir Mal Foie (1970) 0.92
Viral load in HCV RNA-positive pregnant women. Am J Gastroenterol (2001) 0.92
Immunity to poliovirus among children and the elderly in north-east Italy. J Prev Med Hyg (2006) 0.92
Assessing patients' understanding of hepatitis C virus infection and its impact on their lifestyle. Aliment Pharmacol Ther (2006) 0.91
Localization of hepatitis C virus (HCV) antigen by immunohistochemistry on fixed-embedded liver tissue. Ital J Gastroenterol (1990) 0.91
MF59-adjuvanted influenza vaccine confers superior immunogenicity in adult subjects (18-60 years of age) with chronic diseases who are at risk of post-influenza complications. Vaccine (2007) 0.91
Quality of life after proctocolectomy and ileo-anal anastomosis for severe ulcerative colitis. Am J Gastroenterol (1998) 0.91
Combined determination of serum CA 19-9 and tissue polypeptide antigen: why no improvement in pancreatic cancer diagnosis? Oncology (1988) 0.91
Nuclear membrane-staining antinuclear antibody in patients with primary biliary cirrhosis. J Clin Immunol (1985) 0.91
Cholestatic jaundice as the presenting symptom of small cell lung cancer. Ital J Gastroenterol (1990) 0.90
Comparison of three different influenza vaccines in institutionalised elderly. Vaccine (2001) 0.90
Levosulpiride in functional dyspepsia: a multicentric, double-blind, controlled trial. Ital J Gastroenterol (1997) 0.90
Hepatocyte tight-junctional permeability is increased in rat experimental colitis. Gastroenterology (1997) 0.90
Histology predicts cirrhotic evolution of post transplant hepatitis C. Gut (2002) 0.89